CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas

Van Anh Ta¹, Maxime Battistella², Lin Pierre Zhao¹, Gabor Dobos³, Caroline Ram-Wolff⁴, Isabelle Madelaine⁵, Jean-Christophe Bories⁶, Olivier Tournilhac⁷, Jacques Rouanet⁸, Richard Veyrat-Masson⁹, Jean-David Bouaziz¹⁰, Anne Marie-Cardine⁶, Martine Bagot¹⁰, Armand Bensussan⁶, Hélène Moins-Teisserenc¹¹, Adèle De Masson¹²

Affiliations

¹ Institut National de la Santé et de la Recherche Médicale (INSERM) U1160, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Institut de Recherche Saint-Louis, Paris, France.
² Université Paris Cité, Institut de Recherche Saint-Louis, Paris, France; Pathology Department, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U976 HIPI, Institut de Recherche Saint-Louis, Paris, France.
³ Department of Dermatology, Charité Hospital, Berlin, Germany.
⁴ Department of Dermatology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁵ Pharmacy, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁶ Université Paris Cité, Institut de Recherche Saint-Louis, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U976 HIPI, Institut de Recherche Saint-Louis, Paris, France.
⁷ Department of Hematology, Centre Hospitalier Universitaire (CHU) Clermont-Ferrand, Clermont-Ferrand, France.
⁸ Department of Dermatology, Centre Hospitalier Universitaire (CHU) Clermont-Ferrand, Clermont-Ferrand, France.
⁹ Hematology Laboratory, Centre Hospitalier Universitaire (CHU) Clermont-Ferrand, Clermont-Ferrand, France.
¹⁰ Université Paris Cité, Institut de Recherche Saint-Louis, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U976 HIPI, Institut de Recherche Saint-Louis, Paris, France; Department of Dermatology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
¹¹ Institut National de la Santé et de la Recherche Médicale (INSERM) U1160, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Institut de Recherche Saint-Louis, Paris, France; Hematology Laboratory, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
¹² Université Paris Cité, Institut de Recherche Saint-Louis, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U976 HIPI, Institut de Recherche Saint-Louis, Paris, France; Department of Dermatology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. Electronic address: adele.demasson@aphp.fr.

PMID: 36716922
DOI: 10.1016/j.jid.2023.01.009

Free article

CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas

Van Anh Ta et al. J Invest Dermatol. 2023 Jul.

Free article

. 2023 Jul;143(7):1329-1332.e3.

doi: 10.1016/j.jid.2023.01.009. Epub 2023 Jan 28.

Authors

Affiliations

¹ Institut National de la Santé et de la Recherche Médicale (INSERM) U1160, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Institut de Recherche Saint-Louis, Paris, France.
² Université Paris Cité, Institut de Recherche Saint-Louis, Paris, France; Pathology Department, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U976 HIPI, Institut de Recherche Saint-Louis, Paris, France.
³ Department of Dermatology, Charité Hospital, Berlin, Germany.
⁴ Department of Dermatology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁵ Pharmacy, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁶ Université Paris Cité, Institut de Recherche Saint-Louis, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U976 HIPI, Institut de Recherche Saint-Louis, Paris, France.
⁷ Department of Hematology, Centre Hospitalier Universitaire (CHU) Clermont-Ferrand, Clermont-Ferrand, France.
⁸ Department of Dermatology, Centre Hospitalier Universitaire (CHU) Clermont-Ferrand, Clermont-Ferrand, France.
⁹ Hematology Laboratory, Centre Hospitalier Universitaire (CHU) Clermont-Ferrand, Clermont-Ferrand, France.
¹⁰ Université Paris Cité, Institut de Recherche Saint-Louis, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U976 HIPI, Institut de Recherche Saint-Louis, Paris, France; Department of Dermatology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
¹¹ Institut National de la Santé et de la Recherche Médicale (INSERM) U1160, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Institut de Recherche Saint-Louis, Paris, France; Hematology Laboratory, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
¹² Université Paris Cité, Institut de Recherche Saint-Louis, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U976 HIPI, Institut de Recherche Saint-Louis, Paris, France; Department of Dermatology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. Electronic address: adele.demasson@aphp.fr.

PMID: 36716922
DOI: 10.1016/j.jid.2023.01.009

No abstract available

PubMed Disclaimer

Comment in

CD38 Targeting Holds Potential for the Treatment of Aggressive Refractory Cutaneous T-Cell Lymphomas.
Pavlova O, Tsai YC, Chang YT, Vonow Eisenring M, Guenova E. Pavlova O, et al. J Invest Dermatol. 2023 Jul;143(7):1122-1126. doi: 10.1016/j.jid.2023.02.011. Epub 2023 Mar 16. J Invest Dermatol. 2023. PMID: 36933969 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas

Affiliations

CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas

Authors

Affiliations

Comment in

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Research Materials